A combined screening platform for HIV treatment failure and resistance.
To develop a low cost method to screen for virologic failure of antiretroviral therapy (ART) and HIV-1 drug resistance, we performed a retrospective evaluation of a screening assay using serial dilutions of HIV-1 RNA-spiked blood plasma and samples from patients receiving >6 months of first-line...
Main Authors: | Myres W Tilghman, Susanne May, Josué Pérez-Santiago, Caroline C Ignacio, Susan J Little, Douglas D Richman, Davey M Smith |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3338506?pdf=render |
Similar Items
-
HIV-1 clade B pol evolution following primary infection.
by: George K Hightower, et al.
Published: (2013-01-01) -
Signs or Symptoms of Acute HIV Infection in a Cohort Undergoing Community-Based Screening
by: Martin Hoenigl, et al.
Published: (2016-03-01) -
IDEPI: rapid prediction of HIV-1 antibody epitopes and other phenotypic features from sequence data using a flexible machine learning platform.
by: N Lance Hepler, et al.
Published: (2014-09-01) -
Temporal variation in HIV-specific IgG subclass Abs during acute infection differentiates spontaneous controllers from chronic progressors
by: Sadanand, Saheli, et al.
Published: (2019) -
Single crystal growth and characterization of silicon germanium alloys
by: Rittenhouse, Tilghman L. (Tilghman Lee), 1972-
Published: (2014)